AstraZeneca opens new manufacturing facility to support continued growth in Russia
20-Oct-15, AstraZeneca
AstraZeneca today announced the opening of its new state-of-the-art manufacturing and packaging facility in Kaluga, Russia, dedicated to the local supply of innovative medicines.
%20AstraZeneca.png "AstraZeneca opens new manufacturing facility to support continued growth in Russia (c) AstraZeneca")
Image: AstraZeneca
In 2011 AstraZeneca was one of the first multinational pharmaceutical companies to announce plans to invest in the construction of a dedicated manufacturing facility in Russia. Four years on, the Company has invested $224m in the development, which is the largest foreign investment in the construction of a new pharmaceutical facility in the country.
Pascal Soriot, Chief Executive Officer, said: “Our new dedicated production facility will support our efforts to bring innovative medicines from our exciting pipeline to patients in Russia. This opening builds on our investments in clinical research and scientific collaborations in this important country and serves to reinforce our long term commitment to Russia.”